Alpine Immune Sciences Inc (DELISTED) (ALPN:DL)
Alpine Immune Sciences Market Cap: 4.457B for May 20, 2024
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 114.84B |
| Climb Bio, Inc. | 266.60M |
| Regeneron Pharmaceuticals, Inc. | 79.44B |
| Vera Therapeutics, Inc. | 3.205B |
| Hyperion DeFi, Inc. | 25.51M |
Market Cap Related Metrics
| PS Ratio | 62.20 |
| Price to Book Value | 13.40 |
| Earnings Yield | -0.99% |